17.01.2014 Views

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN ...

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN ...

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

246,000 “prescriptions” for controlled substances. Id. 14. Approximately 80% of the<br />

“prescriptions” were for Hydrocodone, a/k/a Vicodin, Lortab, Lorcet, Norco and Zydone,<br />

a Schedule III controlled substance that is used for pain relief. Id. The remaining 20%<br />

of the “prescriptions” were for Schedule IV controlled substances, such as<br />

Benzodiazepines, Propoxyphene and Phentermine. Id. Pharmacom’s doctors and<br />

pharmacists helped to dispense more than 12.5 million Schedule III dosage units and more<br />

than 1.9 million Schedule IV dosage units. Pharmacom’s customers paid in excess of $40<br />

million for their “prescriptions.” Id.<br />

Pharmacom used the proceeds of its unlawful activity to pay doctors a total of<br />

approximately $2.29 million for authorizing “prescriptions.” Id. 24. Pharmacom paid<br />

a total of approximately $2.26 million to the pharmacies for filling the orders. The funds<br />

deposited into the bank accounts of the doctors and the pharmacies allowed them to<br />

continue operating as critical members of the drug conspiracy. Pharmacom also paid<br />

approximately $7.75 million to acquire the Schedule III and IV controlled substances;<br />

$1.60 million for shipping costs; $3.14 million for marketing costs, including Internet<br />

advertising; and $1.99 million to its employees to help operate its business. These<br />

financial transactions total approximately $19 million.<br />

The original defendants and others acting at their behest conspired to create various<br />

shell corporations to conceal the nature, location, source, ownership and control of the<br />

proceeds from the conspiracy’s unlawful activity. Together, they shifted drug proceeds<br />

to these shell corporations. The shell corporations were almost all Florida corporations,<br />

with the exception of one corporation registered in the U.S. Virgin Islands. Pharmacom<br />

also sent money to various bank accounts or trust accounts controlled by or for the benefit<br />

of the relatives of Birbragher and Kanner.<br />

The original defendants and others working at their behest conducted at least 859<br />

transactions involving $10,000 in drug proceeds.<br />

10

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!